CCCC
C4 Therapeutics
Stock NASDAQ – Stock Market Prices, News & Analysis
C4 Therapeutics specializes in the development of innovative cancer treatments using targeted protein degradation technology.
C4 Therapeutics
CCCC
C4 Therapeutics specializes in the development of innovative cancer treatments using targeted protein degradation technology.
Price history of C4 Therapeutics
Price history of C4 Therapeutics
Performance & Momentum
Strategic Analysis
C4 Therapeutics • 2026
C4 Therapeutics is a biotechnology company focused on targeted protein degradation, a next-generation approach designed to attack cancer mechanisms that are difficult to treat with conventional therapies. Its positioning is that of an innovative, specialized player, whose value rests on the quality of its scientific platform and its ability to turn this technology into credible drug candidates.
- Differentiated targeted protein degradation technology, with a distinct scientific positioning in oncology
- Exposure to a structurally attractive cancer market with a strong need for innovation
- Recent favorable momentum, suggesting renewed market interest in the story
- Speculative biopharmaceutical profile, dependent on clinical, regulatory, and partnership success
- Very poor long-term stock market performance, indicating high volatility and limited past investor confidence
Momentum appears to have improved significantly and reflects a rebound after a very long period of underperformance. The recent trend is constructive for a biotechnology name, which may indicate growing investor interest in the platform or development milestones, but the profile remains that of a stock driven more by scientific conviction than by established fundamental visibility.
Similar stocks to C4 Therapeutics
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
